US Stock MarketDetailed Quotes

IDEXX Laboratories Inc (IDXX)

Watchlist
  • 557.910
  • +0.970+0.17%
Close Jun 11 16:00 ET
  • 557.910
  • 0.0000.00%
Post 20:01 ET
44.01BMarket Cap41.05P/E (TTM)

IDEXX Laboratories Inc (IDXX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
14.26%1.14B
10.42%4.3B
14.28%1.09B
13.29%1.11B
10.55%1.11B
3.56%998.43M
6.46%3.9B
5.84%954.29M
6.56%975.54M
6.35%1B
Operating revenue
14.26%1.14B
10.42%4.3B
14.28%1.09B
13.29%1.11B
10.55%1.11B
3.56%998.43M
6.46%3.9B
5.84%954.29M
6.56%975.54M
6.35%1B
Cost of revenue
11.47%418.08M
8.27%1.64B
12.73%432.47M
11.17%421.89M
7.88%414.73M
1.08%375.05M
3.24%1.52B
2.18%383.63M
3.25%379.51M
3.68%384.42M
Gross profit
15.94%722.74M
11.80%2.66B
15.33%658.11M
14.65%683.35M
12.21%694.73M
5.11%623.38M
8.63%2.38B
8.46%570.66M
8.77%596.04M
8.08%619.16M
Operating expense
17.37%360.15M
3.91%1.3B
10.85%342.51M
12.45%328.51M
-9.48%321.69M
4.33%306.85M
14.43%1.25B
10.01%308.97M
7.13%292.15M
28.42%355.36M
Selling and administrative expenses
18.80%294.37M
1.70%1.05B
9.72%275.68M
11.31%265.09M
-13.38%259.79M
2.61%247.78M
14.29%1.03B
9.69%251.25M
5.98%238.17M
30.28%299.91M
-Selling and marketing expense
12.18%175.25M
9.35%643.55M
11.29%167.06M
8.80%159.16M
12.93%161.11M
4.53%156.22M
3.96%588.51M
5.69%150.11M
7.80%146.28M
1.52%142.67M
-General and administrative expense
30.09%119.12M
-8.48%404.79M
7.39%108.62M
15.29%105.94M
-37.24%98.68M
-0.50%91.56M
31.70%442.29M
16.22%101.14M
3.20%91.89M
75.36%157.24M
Research and development costs
11.39%65.79M
14.29%251.21M
15.77%66.83M
17.48%63.42M
11.63%61.9M
12.21%59.06M
15.10%219.79M
11.42%57.73M
12.53%53.98M
19.23%55.45M
Operating profit
14.55%362.59M
20.53%1.36B
20.60%315.61M
16.77%354.85M
41.41%373.05M
5.88%316.53M
2.84%1.13B
6.68%261.69M
10.39%303.89M
-10.92%263.8M
Net non-operating interest income expense
-10.76%-7.14M
-93.68%-35.84M
-62.73%-8.62M
-102.19%-10.08M
-125.37%-10.69M
-85.40%-6.45M
48.53%-18.51M
5.95%-5.3M
32.59%-4.98M
53.55%-4.75M
Non-operating interest income
-50.90%597K
-76.30%3.01M
-73.31%587K
-78.63%580K
-81.31%627K
-72.56%1.22M
125.60%12.7M
-39.44%2.2M
116.25%2.71M
925.69%3.35M
Non-operating interest expense
0.98%7.74M
24.51%38.85M
22.83%9.21M
38.43%10.66M
39.78%11.32M
-3.10%7.67M
-24.95%31.21M
-19.07%7.5M
-10.99%7.7M
-23.17%8.1M
Other net income (expense)
Income before tax
14.63%355.44M
19.31%1.32B
19.73%306.98M
15.34%344.77M
39.87%362.35M
4.94%310.08M
4.59%1.11B
6.98%256.39M
11.58%298.91M
-9.40%259.06M
Income tax
14.23%77M
19.26%264.73M
46.12%58.79M
6.20%70.16M
22.61%68.36M
12.53%67.41M
2.70%221.96M
-10.87%40.24M
18.70%66.07M
-9.62%55.76M
Net income
14.74%278.45M
19.33%1.06B
14.82%248.19M
17.94%274.61M
44.61%293.99M
3.01%242.68M
5.07%887.87M
11.12%216.15M
9.71%232.84M
-9.34%203.3M
Net income continuous Operations
14.74%278.45M
19.33%1.06B
14.82%248.19M
17.94%274.61M
44.61%293.99M
3.01%242.68M
5.07%887.87M
11.12%216.15M
9.71%232.84M
-9.34%203.3M
Minority interest income
Net income attributable to the parent company
14.74%278.45M
19.33%1.06B
14.82%248.19M
17.94%274.61M
44.61%293.99M
3.01%242.68M
5.07%887.87M
11.12%216.15M
9.71%232.84M
-9.34%203.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.74%278.45M
19.33%1.06B
14.82%248.19M
17.94%274.61M
44.61%293.99M
3.01%242.68M
5.07%887.87M
11.12%216.15M
9.71%232.84M
-9.34%203.3M
Basic earnings per share
17.45%3.5
22.28%13.17
17.80%3.11
21.20%3.43
48.78%3.66
4.93%2.98
5.90%10.77
12.82%2.64
10.98%2.83
-8.89%2.46
Diluted earnings per share
17.23%3.47
22.59%13.08
17.56%3.08
21.43%3.4
48.77%3.63
5.34%2.96
6.06%10.67
12.93%2.62
10.67%2.8
-8.61%2.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 14.26%1.14B10.42%4.3B14.28%1.09B13.29%1.11B10.55%1.11B3.56%998.43M6.46%3.9B5.84%954.29M6.56%975.54M6.35%1B
Operating revenue 14.26%1.14B10.42%4.3B14.28%1.09B13.29%1.11B10.55%1.11B3.56%998.43M6.46%3.9B5.84%954.29M6.56%975.54M6.35%1B
Cost of revenue 11.47%418.08M8.27%1.64B12.73%432.47M11.17%421.89M7.88%414.73M1.08%375.05M3.24%1.52B2.18%383.63M3.25%379.51M3.68%384.42M
Gross profit 15.94%722.74M11.80%2.66B15.33%658.11M14.65%683.35M12.21%694.73M5.11%623.38M8.63%2.38B8.46%570.66M8.77%596.04M8.08%619.16M
Operating expense 17.37%360.15M3.91%1.3B10.85%342.51M12.45%328.51M-9.48%321.69M4.33%306.85M14.43%1.25B10.01%308.97M7.13%292.15M28.42%355.36M
Selling and administrative expenses 18.80%294.37M1.70%1.05B9.72%275.68M11.31%265.09M-13.38%259.79M2.61%247.78M14.29%1.03B9.69%251.25M5.98%238.17M30.28%299.91M
-Selling and marketing expense 12.18%175.25M9.35%643.55M11.29%167.06M8.80%159.16M12.93%161.11M4.53%156.22M3.96%588.51M5.69%150.11M7.80%146.28M1.52%142.67M
-General and administrative expense 30.09%119.12M-8.48%404.79M7.39%108.62M15.29%105.94M-37.24%98.68M-0.50%91.56M31.70%442.29M16.22%101.14M3.20%91.89M75.36%157.24M
Research and development costs 11.39%65.79M14.29%251.21M15.77%66.83M17.48%63.42M11.63%61.9M12.21%59.06M15.10%219.79M11.42%57.73M12.53%53.98M19.23%55.45M
Operating profit 14.55%362.59M20.53%1.36B20.60%315.61M16.77%354.85M41.41%373.05M5.88%316.53M2.84%1.13B6.68%261.69M10.39%303.89M-10.92%263.8M
Net non-operating interest income expense -10.76%-7.14M-93.68%-35.84M-62.73%-8.62M-102.19%-10.08M-125.37%-10.69M-85.40%-6.45M48.53%-18.51M5.95%-5.3M32.59%-4.98M53.55%-4.75M
Non-operating interest income -50.90%597K-76.30%3.01M-73.31%587K-78.63%580K-81.31%627K-72.56%1.22M125.60%12.7M-39.44%2.2M116.25%2.71M925.69%3.35M
Non-operating interest expense 0.98%7.74M24.51%38.85M22.83%9.21M38.43%10.66M39.78%11.32M-3.10%7.67M-24.95%31.21M-19.07%7.5M-10.99%7.7M-23.17%8.1M
Other net income (expense)
Income before tax 14.63%355.44M19.31%1.32B19.73%306.98M15.34%344.77M39.87%362.35M4.94%310.08M4.59%1.11B6.98%256.39M11.58%298.91M-9.40%259.06M
Income tax 14.23%77M19.26%264.73M46.12%58.79M6.20%70.16M22.61%68.36M12.53%67.41M2.70%221.96M-10.87%40.24M18.70%66.07M-9.62%55.76M
Net income 14.74%278.45M19.33%1.06B14.82%248.19M17.94%274.61M44.61%293.99M3.01%242.68M5.07%887.87M11.12%216.15M9.71%232.84M-9.34%203.3M
Net income continuous Operations 14.74%278.45M19.33%1.06B14.82%248.19M17.94%274.61M44.61%293.99M3.01%242.68M5.07%887.87M11.12%216.15M9.71%232.84M-9.34%203.3M
Minority interest income
Net income attributable to the parent company 14.74%278.45M19.33%1.06B14.82%248.19M17.94%274.61M44.61%293.99M3.01%242.68M5.07%887.87M11.12%216.15M9.71%232.84M-9.34%203.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.74%278.45M19.33%1.06B14.82%248.19M17.94%274.61M44.61%293.99M3.01%242.68M5.07%887.87M11.12%216.15M9.71%232.84M-9.34%203.3M
Basic earnings per share 17.45%3.522.28%13.1717.80%3.1121.20%3.4348.78%3.664.93%2.985.90%10.7712.82%2.6410.98%2.83-8.89%2.46
Diluted earnings per share 17.23%3.4722.59%13.0817.56%3.0821.43%3.448.77%3.635.34%2.966.06%10.6712.93%2.6210.67%2.8-8.61%2.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran conflict shows signs of easing. On the 11th, Eastern Time, Trump revealed that the United States and Iran are expected to reac Show More